ArticleBritish journal of haematology2026

Retreatment with talquetamab and pomalidomide in triple-class-BCMA-GPRC5D refractory myeloma.

Kian J Rahbari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.